Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity

2019 ◽  
Vol 98 ◽  
pp. 26-31
Author(s):  
Fang Wang ◽  
Jing Zhang ◽  
Gang Zhou
2019 ◽  
Vol 98 ◽  
pp. 115-121
Author(s):  
Hui Wang ◽  
Yuchen Jiang ◽  
Hongning Wang ◽  
Zhenhua Luo ◽  
Yuanyuan Wang ◽  
...  

Blood ◽  
2012 ◽  
Vol 120 (15) ◽  
pp. 3118-3125 ◽  
Author(s):  
Alison M. McInturff ◽  
Mark J. Cody ◽  
Elizabeth A. Elliott ◽  
Jared W. Glenn ◽  
Jesse W. Rowley ◽  
...  

Abstract Neutrophils are highly specialized innate immune effector cells that evolved for antimicrobial host defense. In response to inflammatory stimuli and pathogens, they form neutrophil extracellular traps (NETs), which capture and kill extracellular microbes. Deficient NET formation predisposes humans to severe infection, but, paradoxically, dysregulated NET formation contributes to inflammatory vascular injury and tissue damage. The molecular pathways and signaling mechanisms that control NET formation remain largely uncharacterized. Using primary human neutrophils and genetically manipulated myeloid leukocytes differentiated to surrogate neutrophils, we found that mammalian target of rapamycin (mTOR) regulates NET formation by posttranscriptional control of expression of hypoxia-inducible factor 1 α (HIF-1α), a critical modulator of antimicrobial defenses. Next-generation RNA sequencing, assays of mRNA and protein expression, and analysis of NET deployment by live cell imaging and quantitative histone release showed that mTOR controls NET formation and translation of HIF-1α mRNA in response to lipopolysaccharide. Pharmacologic and genetic knockdown of HIF-1α expression and activity inhibited NET deployment, and inhibition of mTOR and HIF-1α inhibited NET-mediated extracellular bacterial killing. Our studies define a pathway to NET formation involving 2 master regulators of immune cell function and identify potential points of molecular intervention in strategies to modify NETs in disease.


Author(s):  
Martyn Ormond ◽  
Helen McParland ◽  
Priya Thakrar ◽  
Ana Donaldson ◽  
Manoharan Andiappan ◽  
...  

2007 ◽  
Vol 157 (4) ◽  
pp. 765-770 ◽  
Author(s):  
M. Escudier ◽  
N. Ahmed ◽  
P. Shirlaw ◽  
J. Setterfield ◽  
A. Tappuni ◽  
...  

Author(s):  
Thomas E. Bramanti ◽  
Nusi P. Dekker ◽  
Francina Lozada-Nur ◽  
John J. Sauk ◽  
Joseph A. Regezi

2007 ◽  
Vol 27 (3) ◽  
pp. 116-123 ◽  
Author(s):  
L. J. Walton ◽  
M. G. Macey ◽  
M. H. Thornhill ◽  
P. M. Farthing

2012 ◽  
Vol 32 (4) ◽  
pp. 794-801 ◽  
Author(s):  
Gang Zhou ◽  
Jing Zhang ◽  
Xiang-wei Ren ◽  
Jing-yu Hu ◽  
Ge-fei Du ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document